Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer

(MedPage Today) — SAN ANTONIO — Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune activation and tumor response in node-positive hormone receptor-positive (HR+)/HER2-negative breast cancer…

Source link : https://www.medpagetoday.com/meetingcoverage/sabcs/119006

Author :

Publish date : 2025-12-14 22:21:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer

‘Terrible Distortion of All the Facts’: What We Heard This Week

Does NP-Led Remote Tracking Bridge the Gap in Diabetes Care?

Related Posts

A Patient Needs a Drug. They Have Their Own Ideas. What Now?

Skin Imaging App Helps PCPs Reduce Patient Derm Visits

ctDNA Dynamics Predict Response in Early HER2+ Breast Cancer

Does NP-Led Remote Tracking Bridge the Gap in Diabetes Care?

‘Terrible Distortion of All the Facts’: What We Heard This Week

I Co-Discovered HIV. Here Are Lessons to Help Prepare for the Next Threat.

A Patient Needs a Drug. They Have Their Own Ideas. What Now?

Skin Imaging App Helps PCPs Reduce Patient Derm Visits

ctDNA Dynamics Predict Response in Early HER2+ Breast Cancer

Does NP-Led Remote Tracking Bridge the Gap in Diabetes Care?

Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer

‘Terrible Distortion of All the Facts’: What We Heard This Week

I Co-Discovered HIV. Here Are Lessons to Help Prepare for the Next Threat.

Popular Holiday Beverages High In Sugar May Cause Damage

Categories

Archives